SCHEMBL19834036

SCHEMBL19834036

FC(F)(F)C(F)(F)c1ccncc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.48
USP2 O75604 1/20 0.43
RAB9A P51151 1/20 0.43
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
CYP19A1 P11511 1/20 0.38
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35
KMT2A Q03164 2/20 0.35
HDAC8 Q9BY41 1/20 0.35
CYP2D6 P10635 1/20 0.35
CHRM1 P11229 1/20 0.35
MAPK1 P28482 1/20 0.35
KCNA1 Q09470 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CTSD P07339 1/20 0.33
DDAH1 O94760 1/20 0.33
NOS1 P29475 1/20 0.33
PLOD2 O00469 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL173641 0.79 KIF11 (0.70) KIF11USP2RAB9ALMNAMAPT
SCHEMBL9959063 0.78 KIF11 (0.48) KIF11USP2RAB9ALMNAMAPT
Hydrochloric Acid SCHEMBL7816092 0.77 KIF11 (0.67) KIF11USP2RAB9ALMNAMAPT
Ammonia Solution, Strong SCHEMBL28086851 0.77 KIF11 (0.67) KIF11USP2RAB9ALMNAMAPT
Bromide SCHEMBL28026302 0.77 KIF11 (0.67) KIF11USP2RAB9ALMNAMAPT
Fluoride SCHEMBL17966118 0.74 KIF11 (0.64) KIF11USP2RAB9ALMNAMAPT
SCHEMBL24863786 0.74 USP2 (0.50) KIF11USP2RAB9ALMNAMAPT
SCHEMBL13887337 0.74 NR1H2 (0.56) USP2RAB9ACYP19A1MLYCDNR1H2
SCHEMBL12909254 0.72 KIF11 (0.48) KIF11USP2RAB9ALMNAMAPT
SCHEMBL10852484 0.72 KIF11 (0.48) KIF11USP2RAB9ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4318630-B1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY ASAHI CHEMICAL IND (JP) 2025-10-22 EP disclosed
US-12199280-B2 Non-aqueous secondary battery and non-aqueous electrolyte ASAHI KASEI KABUSHIKI KAISHA (JP) 2025-01-14 US disclosed
EP-4415105-A2 NON-AQUEOUS SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTE Asahi Kasei Kabushiki Kaisha (JP) 2024-08-14 EP disclosed
US-20240178452-A1 Nonaqueous Electrolyte Solution and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-05-30 US disclosed
EP-4318630-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY Asahi Kasei Kabushiki Kaisha (JP) 2024-02-07 EP disclosed
WO-2022203072-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY 旭化成株式会社 2022-09-29 WO disclosed
US-20220293929-A1 Non-Aqueous Secondary Battery and Non-Aqueous Electrolyte ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-09-15 US disclosed
EP-4009398-A1 NON-AQUEOUS SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTE Asahi Kasei Kabushiki Kaisha (JP) 2022-06-08 EP disclosed
CN-114342145-A Nonaqueous secondary battery and nonaqueous electrolyte 旭化成株式会社 2022-04-12 CN disclosed
US-10693189-B2 Nonaqueous electrolyte and nonaqueous secondary battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-06-23 US disclosed
EP-3279996-B1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY ASAHI CHEMICAL IND (JP) 2018-12-26 EP disclosed
US-20180062207-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed
EP-3279996-A1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY Asahi Kasei Kabushiki Kaisha (JP) 2018-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220293929-A1 Non-Aqueous Secondary Battery and Non-Aqueous Electrolyte CLK2, TYK2, CLK3 KIF11 1596/4885USP2 2444/4885RAB9A 2233/4885
US-12199280-B2 Non-aqueous secondary battery and non-aqueous electrolyte CLK2, TYK2, CLK3 KIF11 1596/4885USP2 2444/4885RAB9A 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.